James Curtain

Contemporary Post-MI Treatments Reduce Risk of Sudden Death Rates of Sudden Death After Myocardial Infarction—VALIANT and PARADISE-MI Trials James P. Curtain, MB, BS; Marc A. Pfeffer, PhD; Eugene Braunwald, MD; Brian L. Claggett, PhD; Christopher B. Granger, MD; Lars Køber, MD, DSci; Eldrin F. Lewis, MD, MPH; Aldo P. Maggioni, MD; Doug L. Mann, MD; Jean L. Rouleau, MD; Scott D. Solomon, MD; Philippe Gabriel Steg, MD; Peter V. Finn, MD; Alberto Fernandez, MD; Karola S. Jering, MD; John J. V.

Key Points Question Has the sudden death rate after myocardial infarction and the characteristics of people dying suddenly changed over time?

Introduction Patients with heart failure (HF) are admitted to hospital many times during their disease1, 2 for treatment with intravenous (IV) diuretics for the relief of congestion. Although there are protocols to provide IV diuretic therapy in the outpatient setting,3 preventing hospitalizations through the early detection of deterioration and identification of subclinical congestion is preferable, allowing alteration of therapy and preventing hospitalization.